Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reevaluation Of Systemic Early Neuromuscular Blockade

NCT02509078 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02509078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02509078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reevaluation Of Systemic Early Neuromuscular Blockade
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Completed
Start date
January 4, 2016
Completion date
April 4, 2019
Enrollment
1,008 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome